Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.

Bridgewood, C, Alase, A, Watad, A et al. (3 more authors) (2019) Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 68 (6). p. 427. ISSN 1023-3830

Abstract

Metadata

Authors/Creators:
Commentary on: Bridgewood, C orcid.org/0000-0002-3083-3076, Alase, A, Watad, A et al. (3 more authors) (2019) The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man. Inflammation Research, 68 (6). pp. 423-426. ISSN 1023-3830
Copyright, Publisher and Additional Information: © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Dates:
  • Accepted: 13 April 2019
  • Published (online): 7 May 2019
  • Published: June 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Aug 2019 14:03
Last Modified: 07 Aug 2019 14:09
Status: Published
Publisher: Springer
Identification Number: https://doi.org/10.1007/s00011-019-01242-y

Commentary/Response Threads

Export

Statistics